about
How I treat acquired aplastic anemiaBone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism miceERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function.Gene expression profiling identifies HOXB4 as a direct downstream target of GATA-2 in human CD34+ hematopoietic cells.Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemiaEzh2 regulates transcriptional and posttranslational expression of T-bet and promotes Th1 cell responses mediating aplastic anemia in mice.The herbal decoction modified Danggui Buxue Tang attenuates immune-mediated bone marrow failure by regulating the differentiation of T lymphocytes in an immune-induced aplastic anemia mouse model.Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.Incidence and clinical characteristics of clonal cytogenetic abnormalities of acquired aplastic anemia in adultsIFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.Abnormal immunomodulatory ability on memory T cells in humans with severe aplastic anemia.Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.CD34+ gene expression profiling of individual children with very severe aplastic anemia indicates a pathogenic role of integrin receptors and the proapoptotic death ligand TRAIL.Identification of novel microRNA signatures linked to acquired aplastic anemia.Acute promyelocytic leukemia transformation in a patient with aplastic anemia: a case report with literature review.Clonal evolution and clinical significance of copy number neutral loss of heterozygosity of chromosome arm 6p in acquired aplastic anemiaSyngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the EurAcquired aplastic anemia in children.Necroptosis in spontaneously-mutated hematopoietic cells induces autoimmune bone marrow failure in miceHematopoietic stem cell development, aging and functional failure.The Third Consensus Conference on the treatment of aplastic anemia.Treatment of refractory or relapsed acquired aplastic anemia: review of established and experimental approaches.Treatment of paroxysmal nocturnal hemoglobinuria in the era of eculizumab.How I manage aplastic anaemia in children.New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia.Aplastic anemia as a feature of systemic lupus erythematosus: a case report and literature review.Sirolimus-based immunosuppression as GVHD prophylaxis after bone marrow transplantation for severe aplastic anaemia: a case report and review of the literatureUpdate on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease.Toll-like receptor signaling in hematopoietic homeostasis and the pathogenesis of hematologic diseases.Clinical significance of acquired somatic mutations in aplastic anaemia.Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatmentPharmacokinetics and pharmacodynamics of two antithymocyte globulins in treatment of pediatric aplastic anemia.Second allogeneic stem cell transplant for aplastic anaemia: a retrospective study by the Severe Aplastic Anaemia Working Party of the European Society for Blood and Marrow Transplantation.Comparison of porcine anti-human lymphocyte globulin and rabbit anti-human thymocyte globulin in the treatment of severe aplastic anemia: a retrospective single-center study.Mutations of ASXL1 and TET2 in aplastic anemia.Mesenchymal Stem Cell Benefits Observed in Bone Marrow Failure and Acquired Aplastic Anemia.Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.The shortening telomere length of T lymphocytes maybe associated with hyper‑function in servere aplastic anemia.
P2860
Q24617687-50152A6D-18CB-4AC4-B5ED-AD8924914870Q30009268-F16C095C-E6FE-4A3B-BE41-3FE57EEFB26DQ32884456-1D41ADE3-FB35-48E6-80F7-AB8103A885F2Q33403621-5A07E471-8B8D-424A-BBAE-FAFA62F90B86Q33660516-D25AAD37-DCC9-48F7-8522-F2C43479C1D7Q33824617-9E82C0A0-42F8-423B-8D0E-418CF7C71E5EQ33880590-B641850B-84CB-4F9D-B29F-1F378EFE0200Q34108254-3E7FFA34-54CF-4DBB-99BC-389271BF1A7AQ34501072-E69E59C1-D1CE-4890-BDCF-27EC81D9B7BAQ34683972-59FB9919-4BE8-47EF-BFBF-94B2BB3E3683Q35136867-8A8B6658-C2FF-4058-B9E1-B19C41C011E7Q35740966-DB0BC63A-4C07-41AA-A9CA-1D9B62F87AE4Q36038886-EB6D1E4C-843A-4A3F-9FCA-3E7D747CCAF1Q36204561-BDF4A5B2-242E-433C-AF6E-CC4E430C64B9Q36216179-B121622F-73B2-4B3F-8C67-5E935D308B40Q36337576-61F7C7B9-DB18-4322-9BED-2015A77C2C7EQ36492822-F6920990-F054-46FF-B5F5-3FC7869B3FD2Q36535499-1AB6BA8A-14B2-4580-B576-656BF7AE5CABQ37273222-A8B8A59E-9351-48E2-A32C-7782B94EF6DFQ37490754-D5DBE2E0-49FD-473C-96E1-5191AEF5CEE7Q37618824-56357045-F2D6-4E1A-818C-8A13FFD3806CQ37869367-FBD993D1-DD28-4ABD-BFDE-82FEA2EA4B3FQ37880645-18FB864A-D90A-4465-88FF-6B1AF6EC4B8EQ37884078-A6483D89-C87C-4837-A657-BA6561062E83Q37924893-EC6C2072-9A4A-42D6-B320-06DA5C23153FQ37986162-C6C423E1-FF00-47BB-AC51-177FF85CD8ACQ38160780-92EF016E-8F7C-4E15-94BA-514A8E53D729Q38263670-B9F5D231-4C8F-4529-AB4F-A00D5EF041ECQ38335265-D231BD63-9CC4-4476-8447-669E67B5D091Q38363645-695002E5-9DA3-42EC-B6C7-3AC560DD25B1Q38571471-B26439E4-9768-4BEF-8B87-BC5E3263838CQ38809618-76207C12-E076-4091-A3B2-8326F89C8BC5Q41004126-8E728C20-6130-48CC-9157-3901BA0D09EFQ41048371-B9BC789D-4094-4EA2-AAC7-6636AC086A67Q41455084-2AD50C35-CD0C-49D2-BAC3-5611111CE053Q41743182-2FD3899B-6A3F-4FD0-99A1-D016651F8DF6Q42573865-C1B67E53-8160-4B53-A1FC-557D75A4658AQ48247347-CB7F7797-BC4E-45A9-A78E-65E15D68F612Q48945264-BAFB9081-58C8-4E70-B676-87A2F6A7E997Q49730181-E94C3A83-27EB-469C-BDAA-1F120D548E04
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Aplastic anemia: pathophysiology and treatment.
@ast
Aplastic anemia: pathophysiology and treatment.
@en
type
label
Aplastic anemia: pathophysiology and treatment.
@ast
Aplastic anemia: pathophysiology and treatment.
@en
prefLabel
Aplastic anemia: pathophysiology and treatment.
@ast
Aplastic anemia: pathophysiology and treatment.
@en
P2093
P2860
P1476
Aplastic anemia: pathophysiology and treatment.
@en
P2093
Andrea Bacigalupo
Judith C W Marsh
Neal S Young
P2860
P304
P356
10.1016/J.BBMT.2009.09.013
P433
P577
2009-09-24T00:00:00Z